Doctors say men should not wait for symptoms to ask about prostate cancer screening.

In a population-based cohort study, a single prostate-specific antigen (PSA) measurement in men aged 45-70 years effectively identified individuals with low risk for cancer. Men with PSA levels < 1.00 ...

Prostate cancer (PCa) is the second most common malignancy in men world-wide. Serum prostate-specific antigen (PSA) has been the common method of PCa diagnosis for decades 1. Recent randomised trials ...

A single PSA test at midlife may identify men with a low risk of prostate cancer for up to 20 years, supporting longer screening intervals. Men with a low baseline PSA level at midlife have a low risk ...

A PSA blood test can help find prostate cancer, but experts often disagree on who needs one and what the results actually ...

News that former President Joseph Biden has advanced prostate cancer has revived long-standing questions about the benefits versus the harms of a blood test that screens for the most commonly ...

In a study involving more than 11,000 men enrolled in the Prostate, Lung, Colorectal, and Ovarian (PLCO) cancer screening trial, about one quarter of elevated prostate-specific antigen (PSA) results ...

Prostate cancer is the most common cancer in Australia, with about 26,000 men diagnosed per year. The majority (more than 85%) are aged over 60. Prostate cancer kills around 3,900 Australians a year.

Among men with PSA persistence after radical prostatectomy, a higher preoperative PSA surprisingly was linked to lower mortality. Men with PSA persistence and preoperative PSA >20 ng/mL had 31% lower ...

A new test could be more effective at detecting dangerous prostate cancer than current screening methods, a study suggests.

A funny thing happens when men get together. We will spend hours debating sports. We know exactly when the fishing is best.